期刊文献+

生物素化壳聚糖修饰的PLGA纳米粒的制备及表征 被引量:8

Preparation and Characterization of PLGA Nanospheres Surface Modified with Biotinylated Chitosan
在线阅读 下载PDF
导出
摘要 合成了生物素化壳聚糖(Bio-CS),并通过核磁共振(1HNMR)及电感耦合等离子体光质谱法(ICP-MS)对其进行结构确证.采用溶剂挥发法(W1/O/W2)制备聚乳酸-羟基乙醇酸(PLGA)纳米粒,并通过共价交联法对纳米粒进行Bio-CS表面修饰.未修饰的PLGA纳米粒在扫描电镜下观察呈规则球状形态,平均粒径为(248.4±21.0)nm,Zeta电势为-(21.21±2.13)mV,Bio-CS修饰后的PLGA纳米粒保持球状形态,平均粒径为(268.3±23.4)nm,Zeta电势为(25.45±2.59)mV.采用X射线光电子能谱(XPS)以及试剂盒对纳米粒表面生物素进行定性及定量研究,结果显示,经过Bio-CS修饰后的纳米粒表面含有N,S元素,生物素取代度为31%的Bio-CS修饰的PLGA纳米粒,其表面生物素含量为(1.36±0.34)μmol/100mg纳米粒. Biotinylated chitosan(Bio-CS conjugates or Bio-CS) were synthesized and characterized.The degree of substitution(DS),as defined as the number of biotin per 100 anhydroglucose units of CS,was determined by 1H NMR and ICP.Poly(lactic-co-glycolic acid)(PLGA) nanospheres were prepared by a solvent evaporation technique(W1/O/W2).The surface of PLGA nanosphere was modified with Bio-CS by covalent binding.PLGA nanospheres were almost spherical in shape under the scanning electron microscopy(SEM) observation,and their mean diameter determined by the laser light scattering technique was (248.4±21.0) nm.Bio-CS modified PLGA nanospheres were also spherical in shape;their mean diameter and Zeta potential value were (268.3±23.4) nm and-(21.21±2.13) mV,respectively.The surface chemistry of nanospheres was quantitatively studied by X-ray photoelectron spectroscopy(XPS).The results show the N region corresponding to the primary amide of CS and the S region corresponding to the biotin,indicating that PLGA nanospheres were successfully surface-modified with Bio-CS.The content of biotin on the surface of Bio-CS modified PLGA nanospheres with DS of biotin of 31% was determined using a commercially available QuantTagTM Biotin Kit and its value was (1.36±0.34) mol/100 mg.
出处 《高等学校化学学报》 SCIE EI CAS CSCD 北大核心 2010年第8期1682-1687,共6页 Chemical Journal of Chinese Universities
基金 国家重大科学研究计划项目(批准号:2006CB933300) 新乡医学院省级重点学科开放课题资助
关键词 纳米粒 聚乳酸-羟基乙醇酸 生物素化壳聚糖 抗肿瘤 Nanoparticle Poly(lactic-co-glycolic acid)(PLGA) Biotinylated chitosan anticancer
  • 相关文献

参考文献25

  • 1Awesh K.Y.,Pradeep M.,Anil K.M.,Pushpa M.,Sanyog J.,Govind P.A..Nanomedicine:NBM[J],2007,3(4):246-257.
  • 2Zhang Z.,Lee S.H.,Feng S.S..Biomaterials[J],2007,28:1889-1899.
  • 3Fischer S.,Allmen E.U.,Men Y.W.,Groettrup M.,Hans P.M.,Gander B..Biomaterials[J],2007,28:994-1004.
  • 4Kocbek P.,Obermajer N.,Cegnar M.,Janko K.,Julijana K..J.Control.Release[J],2007,120:18-26.
  • 5Mundargia R.C.,Babua V.R.,Rangaswamy V.,Pradip P.,Tejraj M.A..J.Control.Release[J],2008,125:193-209.
  • 6Ta H.T.,Dass C.R.,Dunstan D.E..J.Control.Release[J],2008,126:205-216.
  • 7Han H.D.,Song C.K.,Park Y.S.,Noh K.H.,Kim J.H.,Hwang T.,Kim T.W.,Shin B.C..Int.J.Pharm.[J],2008,35:27-34.
  • 8Chatterjeea D.K.,Zhang Y..Sci.Technol.Adv.Mater.[J],2007,8:131-133.
  • 9Chan P.,Kurisawa M.,Chung J.E.,Yang Y.Y..Biomaterials[J],2007,28:540-549.
  • 10官习鹏,全大萍,廖凯荣,麦堪成.壳聚糖修饰PLGA阳离子型纳米微球的制备与表征[J].高等学校化学学报,2006,27(10):1965-1968. 被引量:9

二级参考文献30

  • 1赵洁,全大萍,廖凯荣,伍青.含不同侧氨基密度的PLGA-(ASP-Diol)_x-PLGA共聚物的合成与表征[J].高等学校化学学报,2005,26(8):1570-1573. 被引量:2
  • 2[1]Ferrare G,Rossini S,Giavazzi R,et al. An in vivo model of somatic-cell gene-therapy for human severe combined between GCP/DNA complex and DOTAP/DNA did immunodeficiency[J]. Science,1991,251:1363-1366.
  • 3[2]Hyde SC,Gill DR,Higgins CF,et al. Correction of the ion-transport defect in cystic-fibrosis trasgenic mice by geneimportant role in cell growth[J]. Nature,1993,362:250-255.
  • 4[3]Yoshimura K,Rosenfeld M,Nakamura H,et al. Expression of the Human cystic-fibrosis Transmembrane conductance regulator gene in the mouse lung after in vivo intratracheal plasmid-mediated gene-transfer[J].Nucleic Acids Res,1992,20:3233-3240.
  • 5[4]Miyanohara A,Sharkey F,Witztum JL,et al. Efficient expression of retroviral vector-transduced human low-density lipoprotein (LDL) receptor in LDL receptor-deficient rabbit fibroblasts in vitro[J].Proc Natl Acad Sci USA,1988,85:6538-6542.
  • 6[5]Shigemasa Y,Minami S. Application of Chitin and Chitosan for Biomaterial,Biotechnol[J]. Gen Eng Rev,1995,13:383-420.
  • 7[6]Rao SB,Sharma CP. Use of Chitosan as a Biomaterial-Studies on its safety and hemostatic potential[J].J Biomed Mater Res,1997,34:21-38.
  • 8[7]Wall DA,Wilson G,Hubbard AL. The galactosespecific recognition system of mammalian liver:the route of ligand internalization in rat hepatocytes[J]. Cell,1980,21:79-93.
  • 9[8]Jun-ichi M,Yuichi O,Tatsuro O. Possibility of application of quaternary chitosan having pendant galactose residues as gene delivery tool[J].Carbohydr Polym,1996,29:69-74.
  • 10[9]Gao SY,Chen JN,Xu XR,et al. Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targeting[J]. In J Pharm,2003,255:57-68.

共引文献28

同被引文献156

引证文献8

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部